Under construction – not a live service
Sign in
Taking people in ThailandNo phase

Thai Questionnaire and App for Screening Nerve Pain in Diabetes

Tests a Thai pain questionnaire and app to screen adults with diabetes.

Plain-language title generated from the registry record
Registry title: Thai PainPREDICT Validation Study

Key facts

Where
Pathum Wan, ThailandSee the site

Where in Thailand

  • King Chulalongkorn Memorial hospital, The Thai Red Cross SocietyPathum Wan, ThailandTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Chulalongkorn University
Trial code
NCT07195045
Record updated
3 October 2025
Original description
Painful diabetic neuropathy (PDN) is one of the most common and disabling complications of diabetes mellitus, substantially affecting quality of life, daily functioning, and health system burden. Early identification of PDN is crucial for timely treatment, prevention of complications such as foot ulcers and amputations, and for reducing healthcare costs. However, in Thailand there are limited culturally adapted and validated tools for screening PDN. PainPREDICT is an internationally validated questionnaire designed to characterize neuropathic pain profiles, but its adaptation for Thai patients has not yet been undertaken. In parallel, the use of mobile health technologies (mHealth) has the potential to expand access to screening and monitoring of chronic conditions, particularly in resource-limited settings.Read full original descriptionShow less

Thai Version of PainPREDICT: Translation, Validation, and Mobile Application Development for Screening Painful Diabetic Neuropathy in Diabetes Patients

Painful diabetic neuropathy (PDN) is one of the most common and disabling complications of diabetes mellitus, substantially affecting quality of life, daily functioning, and health system burden. Early identification of PDN is crucial for timely treatment, prevention of complications such as foot ulcers and amputations, and for reducing healthcare costs. However, in Thailand there are limited culturally adapted and validated tools for screening PDN. PainPREDICT is an internationally validated questionnaire designed to characterize neuropathic pain profiles, but its adaptation for Thai patients has not yet been undertaken. In parallel, the use of mobile health technologies (mHealth) has the potential to expand access to screening and monitoring of chronic conditions, particularly in resource-limited settings.

Inclusion: Adults aged 18 years or older; Diagnosed with type 1 diabetes mellitus or type 2 diabetes mellitus; Able to communicate in Thai; Willing and able to provide written informed consent.

Exclusion: Presence of neuropathy due to other causes (e.g., alcohol, chemotherapy, HIV, other systemic diseases); Significant cognitive impairment or neurological conditions that prevent comprehension of the questionnaire; Severe psychiatric illness that interferes with study participation.

ClinicalTrials.gov NCT07195045